Spravato® (Esketamine) Treatment: A New Option for Treatment-Resistant Depression

For individuals struggling with severe depression that does not respond to traditional medications, Spravato® (Esketamine) Treatment offers a new path forward. This innovative therapy is now available to patients in South Carolina and Colorado as part of advanced mental health care.

Spravato® is administered under medical supervision and works differently from standard antidepressants. It targets specific brain pathways associated with mood regulation, often providing relief when other treatments have failed.

This treatment is most effective when integrated into a broader care plan that includes Medication Management, Therapy (Counseling Services), and ongoing monitoring through Telehealth Services. Patients receive structured support before, during, and after treatment to ensure safety and effectiveness.

In many cases, providers may also use GeneSight® Testing (Pharmacogenomic Testing) to evaluate prior medication responses and determine whether alternative approaches like Spravato® are appropriate.

Access to this treatment is expanding across South Carolina — including the Midlands, Lowcountry, and Upstate — as well as throughout Colorado. This ensures that more patients have access to cutting-edge care regardless of location.

However, it’s important to recognize that Spravato® is not intended for immediate crisis situations. If someone is experiencing a medical or mental health emergency, or requires an emergency or crisis service, immediate assistance should be sought.

For those who have not found success with traditional treatments, Spravato® represents hope and a new direction in mental health care.